The Joint (JYNT)
(Delayed Data from NSDQ)
$11.08 USD
+0.03 (0.27%)
Updated Nov 1, 2024 04:00 PM ET
After-Market: $11.07 -0.01 (-0.09%) 7:58 PM ET
3-Hold of 5 3
B Value D Growth D Momentum C VGM
We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies, revised Privacy Policy and Terms of Service.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
$11.08 USD
+0.03 (0.27%)
Updated Nov 1, 2024 04:00 PM ET
After-Market: $11.07 -0.01 (-0.09%) 7:58 PM ET
3-Hold of 5 3
B Value D Growth D Momentum C VGM
Zacks News
4 Breakout Stocks Offering Phenomenal Returns
by Swarup Gupta
If properly implemented, such a strategy has the ability to deliver impressive returns.
Will Joint Corp (JYNT) Continue to Surge Higher?
by Zacks Equity Research
As of late, it has definitely been a great time to be an investor in The Joint Corp. (JYNT).
The Zacks Analyst Blog Highlights: Anthem, Humana, Centene, Molina Healthcare and Joint
by Zacks Equity Research
The Zacks Analyst Blog Highlights: Anthem, Humana, Centene, Molina Healthcare and Joint
Wellcare Health Boosts Healthcare With New Partnerships
by Zacks Equity Research
Wellcare Health (WCG) has been forming strategic alliances in order to improve its healthcare offerings across the nation.
UnitedHealth on A.M.Best's Radar After Buyout Announcement
by Zacks Equity Research
A.M.Best acknowledges UnitedHealth's(UNH) deleveraging strategy and earnings accretion from DaVita Medical Group acquisition.
Community Health (CYH) to Divest 120-Bed Hospital in Florida
by Zacks Equity Research
Community Health (CYH) has been divesting hospitals to lower its debt burden. However, these divestitures have adversely affected the company's top line.
Humana Partners Einstein Healthcare for Value-Based Care
by Zacks Equity Research
Humana (HUM) has been joining forces with other medical sector companies in order to strengthen its presence in value-based healthcare.
Zacks.com featured highlights: Akari Therapeutics, Joint, Tailored Brands, Ardelyx and BioTime
by Zacks Equity Research
Zacks.com featured highlights: Akari Therapeutics, Joint, Tailored Brands, Ardelyx and BioTime
Why It's Wise to Add WellCare (WCG) to Your Portfolio
by Zacks Equity Research
WellCare (WCC) looks a solid bet, driven by its intrinsic potency and favorable earnings growth estimates.
5 Affordable Breakout Stocks Offering Excellent Returns
by Swarup Gupta
If properly implemented, such a strategy has the ability to deliver impressive returns.
Is It Advisable to Add Centene (CNC) to Your Portfolio?
by Zacks Equity Research
Centene (CNC) looks a solid bet, driven by its underlying strength and earnings growth prospects.
UnitedHealth Keeps '17 Guidance & Issues '18 View, Stock Up
by Zacks Equity Research
UnitedHealth's (UNH) strong guidance for 2018 reflects its robust fundamentals amid a volatile regulatory backdrop.
Ensign Group Rides on Inorganic Growth, High Expenses Hurt
by Zacks Equity Research
Although Ensigh Group's (ENSG) revenue growth has been positively impacted by its solid inorganic strategies, it suffers from rising level of expenses that weigh on the margins.
WellCare Health's (WCG) Top Line Grows on Inorganic Efforts
by Zacks Equity Research
WellCare Health (WCG) benefits from several organic and inorganic strategies. Moreover, a solid financial background enhances shareholder's value.
Can Obamacare Brave the Tax Cuts Challenge? 4 Hospital Picks
by Swarup Gupta
The passage of the Senate Republicans draft is far from assured at this point.
Anthem's (ANTM) Notes Receive Rating Action From A.M Best
by Zacks Equity Research
Anthem (ANTM) receives favorable ratings from the rating agencies on the back of operational excellence and financial flexibility
Will Health Insurers Have to Rework Under ACHA?
by Zacks Equity Research
The overall expectation is that the new regulatory framework will provide for a relatively lighter regulatory touch and will be friendlier to the industry. That said, the expected change would have some negative effects on the industry as well.
WellCare Health Plans Prices Senior Notes Worth $1.2 Billion
by Zacks Equity Research
WellCare Health Plans, Inc. (WCG) issued 5.25% $1.2 billion senior notes with maturity scheduled on Apr 1, 2025.
Humana (HUM) Includes Methodist Healthcare in its Network
by Zacks Equity Research
Humana Inc. (HUM) recently entered into an agreement with Methodist Healthcare to provide better service to its patients.
The Zacks Analyst Blog Highlights: BioTelemetry, WellCare Health Plans, Joint, HCA Holdings and Chemed
by Zacks Equity Research
The Zacks Analyst Blog Highlights: BioTelemetry, WellCare Health Plans, Joint, HCA Holdings and Chemed
Will Joint (JYNT) Continue to Surge Higher?
by Zacks Equity Research
As of late, it has definitely been a great time to be an investor in Joint Corp. (JYNT)
Will Trump Era Mean Disaster for Health Insurers?
by Mark Vickery
Health insurance companies provided a major overhaul of their business plans to comply with Obamacare, and now they look to be put on a new road forward.